acrizanib | Interleukin Related interleukin-related.com

Product Name :
acrizanib

Search keywords :
Acrizanib

drugId :
null

Target Vo:
Vascular endothelial growth factor A

Target Vo Short Name :
VEGFA

Moa_Name:
Vascular endothelial growth factor A inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Alcon

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Macular Degeneration

Termination Status :
Phase 2 Clinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
p53 Rabbit mAb site
Angiopoietin 1 Antibody (YA1592) Purity & Documentation
EGR1 Antibody: EGR1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 58 kDa., targeting to EGR1. It can be used for WB,IHC-P assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts